140 related articles for article (PubMed ID: 2544590)
61. In vivo localization of DNA topoisomerase II cleavage sites on Drosophila heat shock chromatin.
Rowe TC; Wang JC; Liu LF
Mol Cell Biol; 1986 Apr; 6(4):985-92. PubMed ID: 3023886
[TBL] [Abstract][Full Text] [Related]
62. The effect of AT and GC sequence specific minor groove-binding agents on restriction endonuclease activity.
Forrow SM; Lee M; Souhami RL; Hartley JA
Chem Biol Interact; 1995 May; 96(2):125-42. PubMed ID: 7728903
[TBL] [Abstract][Full Text] [Related]
63. Topoisomerase II cleavage in chromatin.
Udvardy A; Schedl P; Sander M; Hsieh TS
J Mol Biol; 1986 Sep; 191(2):231-46. PubMed ID: 3027349
[TBL] [Abstract][Full Text] [Related]
64. Protection of particular endonuclease R. Hind III cleavage sites by distamycin A, propyl-distamycin and netropsin.
Nosikov VV; Sain B
Nucleic Acids Res; 1977 Jul; 4(7):2263-73. PubMed ID: 909774
[TBL] [Abstract][Full Text] [Related]
65. Effect of netropsin, distamycin A and chromomycin A3 on the binding and cleavage reaction of DNA gyrase.
Simon H; Wittig B; Zimmer C
FEBS Lett; 1994 Oct; 353(1):79-83. PubMed ID: 7926028
[TBL] [Abstract][Full Text] [Related]
66. Identification within the simian virus 40 genome of a chromosomal loop attachment site that contains topoisomerase II cleavage sites.
Pommier Y; Cockerill PN; Kohn KW; Garrard WT
J Virol; 1990 Jan; 64(1):419-23. PubMed ID: 2152827
[TBL] [Abstract][Full Text] [Related]
67. DNase I susceptibility of bent DNA and its alteration by ditercalinium and distamycin.
Mendoza R; Markovits J; Jaffrezou JP; Muzard G; Le Pecq JB
Biochemistry; 1990 May; 29(21):5035-43. PubMed ID: 2198937
[TBL] [Abstract][Full Text] [Related]
68. Drug sensitivity and sequence specificity of human recombinant DNA topoisomerases IIalpha (p170) and IIbeta (p180).
Cornarotti M; Tinelli S; Willmore E; Zunino F; Fisher LM; Austin CA; Capranico G
Mol Pharmacol; 1996 Dec; 50(6):1463-71. PubMed ID: 8967966
[TBL] [Abstract][Full Text] [Related]
69. Topoisomerase II-mediated DNA cleavage by amonafide and its structural analogs.
Hsiang YH; Jiang JB; Liu LF
Mol Pharmacol; 1989 Sep; 36(3):371-6. PubMed ID: 2550774
[TBL] [Abstract][Full Text] [Related]
70. Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin.
Capranico G; Palumbo M; Tinelli S; Zunino F
J Biol Chem; 1994 Oct; 269(40):25004-9. PubMed ID: 7929186
[TBL] [Abstract][Full Text] [Related]
71. Chromatin structure, not DNA sequence specificity, is the primary determinant of topoisomerase II sites of action in vivo.
Udvardy A; Schedl P
Mol Cell Biol; 1991 Oct; 11(10):4973-84. PubMed ID: 1656219
[TBL] [Abstract][Full Text] [Related]
72. Minor groove to major groove, an unusual DNA sequence-dependent change in bend directionality by a distamycin dimer.
Wang S; Munde M; Wang S; Wilson WD
Biochemistry; 2011 Sep; 50(35):7674-83. PubMed ID: 21800847
[TBL] [Abstract][Full Text] [Related]
73. Molecular dynamics investigation of the interaction between DNA and distamycin.
Boehncke K; Nonella M; Schulten K; Wang AH
Biochemistry; 1991 Jun; 30(22):5465-75. PubMed ID: 2036415
[TBL] [Abstract][Full Text] [Related]
74. DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter region.
Pommier Y; Poddevin B; Gupta M; Jenkins J
Biochem Biophys Res Commun; 1994 Dec; 205(3):1601-9. PubMed ID: 7811242
[TBL] [Abstract][Full Text] [Related]
75. DNA abasic lesions in a different light: solution structure of an endogenous topoisomerase II poison.
Cline SD; Jones WR; Stone MP; Osheroff N
Biochemistry; 1999 Nov; 38(47):15500-7. PubMed ID: 10569932
[TBL] [Abstract][Full Text] [Related]
76. DNA topoisomerase II isozymes involved in anticancer drug action and resistance.
Fernandes DJ; Qiu J; Catapano CV
Adv Enzyme Regul; 1995; 35():265-81. PubMed ID: 7572348
[TBL] [Abstract][Full Text] [Related]
77. Hydroxyl radical footprinting of the sequence-selective binding of netropsin and distamycin to DNA.
Portugal J; Waring MJ
FEBS Lett; 1987 Dec; 225(1-2):195-200. PubMed ID: 2826238
[TBL] [Abstract][Full Text] [Related]
78. Determination of 5' and 3' DNA triplex interference boundaries reveals the core DNA binding sequence for topoisomerase II.
Spitzner JR; Chung IK; Muller MT
J Biol Chem; 1995 Mar; 270(11):5932-43. PubMed ID: 7890724
[TBL] [Abstract][Full Text] [Related]
79. Mode of action of topoisomerase II-targeting agents at a specific DNA sequence. Uncoupling the DNA binding, cleavage and religation events.
Sørensen BS; Sinding J; Andersen AH; Alsner J; Jensen PB; Westergaard O
J Mol Biol; 1992 Dec; 228(3):778-86. PubMed ID: 1335085
[TBL] [Abstract][Full Text] [Related]
80. Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1.
Ebert SN; Subramanian D; Shtrom SS; Chung IK; Parris DS; Muller MT
J Virol; 1994 Feb; 68(2):1010-20. PubMed ID: 8289331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
